Life Sciences & Biomedicine Physiology Science & Technology
New Findings
LVAD patients are predisposed to hypertension which may increase the risk of stroke. Hypertension may result from markedly elevated levels of sympathetic nerve activity, which occurs through a baroreceptor-mediated pathway in response to chronic exposure to a non-physiologic (and reduced) pulse.
Cerebral autoregulatory processes appear to be preserved in the absence of a physiologic pulse. Nevertheless, the rate of ischemic/embolic and hemorrhagic stroke is unacceptably high and is a major cause of morbidity and mortality in these patients.
Despite normalization of a resting cardiac output, LVAD patients suffer from persistent, severe reductions in functional capacity.
Current generation left ventricular assist devices (LVADs) have led to significant improvements in survival compared to medical therapy alone, when used for management of patients with advanced heart failure. However, there are a number of side-effects associated with LVAD use, including hypertension, gastrointestinal bleeding, stroke, as well as persistent and severe limitations in functional capacity despite normalization of a resting cardiac output. These issues are, in large part, related to chronic exposure to a non-physiologic pulse, which contributes to a hyperadrenergic environment characterized by markedly elevated levels of sympathetic nerve activity through a baroreceptor-mediated pathway. In addition, these machines are unable to participate in, or contribute to, normal cardiovascular/autonomic reflexes that attempt to modulate flow through the body. Efforts to advance device technology and develop biologically sensitive devices may resolve these issues, and lead to further improvements in quality-of-life, functional capacity, and ultimately, survival, for the patients they support.
Bionic women and men part 4-cardiovascular, cerebrovascular and exercise responses among patients supported with left ventricular assist devices
Creators
Cullen Buchanan - University of Colorado Anschutz Medical Campus
Manreet Kanwar - Allegheny Health Network
John R. Cockcroft - Cardiff Metropolitan University
Barry McDonnell - Cardiff Metropolitan University
Eric J. Stohr - Cardiff Metropolitan University
William K. Cornwell - University of Colorado Anschutz Medical Campus
Publication Details
Experimental physiology, v 105(5), pp 763-766
Publisher
Wiley
Number of pages
4
Grant note
Medtronic
NIH/NHLBI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
Marie Sklodowska-Curie Grant
Abbott Inc; Abbott Laboratories
Resource Type
Journal article
Language
English
Academic Unit
Cardiology
Web of Science ID
WOS:000520296400001
Scopus ID
2-s2.0-85082412757
Other Identifier
991021932189604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Physiology
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services